Skip to content
healthcare.dev

Acne Relief

NDC 66096-168, Antimonium Crud, Arsenicum Brom, Bovista, Eugenia Jamb, Fluoricum Acidum, Hepar Sulph Calc, Kali Brom, Kali Iod, Kali Mur, Nat Brom, Niccolum Sulph, Phosphoricum AC, Sulphur Iod., liquid, from OHM PHARMA INC..

Product NDC
66096-168
Status
Listed
Labeler
OHM PHARMA INC.
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66096-168 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ANTIMONY TRISULFIDE6 [hp_X]/59mL
  • ARSENIC TRIBROMIDE30 [hp_C]/59mL
  • LYCOPERDON UTRIFORME FRUITING BODY30 [hp_C]/59mL
  • SYZYGIUM JAMBOS SEED14 [hp_X]/59mL
  • HYDROFLUORIC ACID30 [hp_C]/59mL
  • CALCIUM SULFIDE30 [hp_C]/59mL
  • POTASSIUM BROMIDE3 [hp_X]/59mL
  • POTASSIUM IODIDE3 [hp_X]/59mL
  • POTASSIUM CHLORIDE6 [hp_X]/59mL
  • SODIUM BROMIDE4 [hp_X]/59mL
  • NICKEL SULFATE HEXAHYDRATE4 [hp_X]/59mL
  • PHOSPHORIC ACID30 [hp_C]/59mL
  • SULFUR IODIDE14 [hp_X]/59mL

Pharmacologic classes

Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]

Package NDCNDC-11Package
66096-168-056609601680559 mL in 1 PACKAGE (66096-168-05)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 66096-168 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66096-168 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66096-168. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.